Double-Blind Efficacy and Safety of CD5789 (Trifarotene) 50µg/g Cream Versus Vehicle Cream in Acne Vulgaris
Public ClinicalTrials.gov record NCT02556788. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Randomized, Double-Blind, Parallel-Group Vehicle Controlled Study To Compare The Efficacy And Safety Of CD5789 (Trifarotene) 50µg/g Cream Versus Vehicle Cream In Subjects With Acne Vulgaris
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Assessment of the efficacy and safety of CD5789 (Trifarotene) 50µg/g cream applied once daily for 12 weeks in subjects with acne vulgaris.
Study identification
- NCT ID
- NCT02556788
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,212 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 9 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2015 (Type not available)
- Primary completion
- Feb 7, 2017 (Actual)
- Completion
- May 12, 2017 (Actual)
- Last update posted
- Nov 12, 2019
2015 – 2017
United States locations
- U.S. sites
- 29
- U.S. states
- 15
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Galderma Investigational Site | Birmingham | Alabama | 35205 | — |
| Galderma Investigational Site | Phoenix | Arizona | 85032 | — |
| Galderma Investigational Site | Tucson | Arizona | 85712 | — |
| Galderma Investigational Site | Fort Smith | Arkansas | 72916 | — |
| Galderma Investigational Site | Los Angeles | California | 90036 | — |
| Galderma Investigational Site | Murrieta | California | 92562 | — |
| Galderma Investigational Site | Santa Ana | California | 92705 | — |
| Galderma Investigational Site | Aventura | Florida | 33180 | — |
| Galderma Investigational Site | Miami | Florida | 33144 | — |
| Galderma Investigational Site | Miami Lakes | Florida | 33016 | — |
| Galderma Investigational Site | West Palm Beach | Florida | 33406 | — |
| Galderma Investigational Site | Corbin | Kentucky | 40701 | — |
| Galderma Investigational Site | Beverly | Massachusetts | 01915 | — |
| Galderma Investigational Site | Ann Arbor | Michigan | 48103 | — |
| Galderma Investigational Site | Detroit | Michigan | 48202 | — |
| Galderma Investigational Site | Brooklyn | New York | 11203 | — |
| Galderma Investigational Site | Stony Brook | New York | 11790 | — |
| Galderma Investigational Site | Wilmington | North Carolina | 28401 | — |
| Galderma Investigational Site | Fort Washington | Pennsylvania | 19034 | — |
| Galderma Investigational Site | Philadelphia | Pennsylvania | 19103 | — |
| Galderma Investigational Site | Greer | South Carolina | 29650 | — |
| Galderma Investigational Site | Goodlettsville | Tennessee | 37072 | — |
| Galderma Invetsigational site | Austin | Texas | 78759-8858 | — |
| Galderma Investigational Site | Dallas | Texas | 75230-5806 | — |
| Galderma Investigational Site | Houston | Texas | 77004 | — |
| Galderma Investigational Site | Pflugerville | Texas | 78660 | — |
| Galderma Investigational Site | San Antonio | Texas | 78249 | — |
| Galderma Investigational Site | Webster | Texas | 77598 | — |
| Galderma Investigational Site | Walla Walla | Washington | 99362 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 52 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02556788, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 12, 2019 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02556788 live on ClinicalTrials.gov.